Clinical trial
Safety and Efficacy Study of Bimatoprost in the Treatment of Women With Female Pattern Hair Loss
NCT01325350 is registered in ClinicalTrials.gov with Allergan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy Study of Bimatoprost in the Treatment of Women With Female Pattern Hair Loss
- Lead sponsor
- Allergan
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- June 30, 2011
- Completion date
- September 30, 2012
- Enrollment
- 306 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
alopecia, baldness